Author/Authors :
Hajian، Mehdi نويسنده Department of Reproductive Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran , , Hosseini، Sayed Morteza نويسنده Reproduction and Development Department, Royan Institute for Animal Biotechnology, ACECR, Isfahan, Iran , , Ostadhosseini، Somayyeh نويسنده Department of Reproductive Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran , , Nasr-Esfahani، Mohammad Hossein نويسنده Department of Reproductive Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran ,
Abstract :
Background: A unique feature of embryo metabolism is production of reactive oxygen
species (ROS). It is well established that during in vitro culture, ROS levels increase
over normal ranges observed for embryos developed in vivo. This study evaluates and
compares the stepwise pattern of ROS production during in vitro development of reconstructed
goat embryos produced by zona-free method of somatic cell nuclear transfer
(SCNT). Furthermore, the pattern of ROS production of SCNT embryos were compared
with zona free embryos derived from in vitro fertilization (IVF).
Materials and Methods: In this experimental study, zona-free oocytes, SCNT and IVF
embryos at different stages of in vitro development (2, 4, 8, 16-cells, morula, and blastocyst)
were used for assessment of ROS production using 2, 7-dichloro dihydroflourescein
diacetate (DCHFDA) probe and the result were presented as fold increase or decrease
relative zona free oocytes.
Results: The relative level of ROS compared to metaphase-II (MII) oocytes insignificantly
decrease during early stages post embryo reconstitution and regained its value by 8-cell
and morula stage and, significantly increase compared to MII oocytes by blastocyst stage.
Conclusion: The pattern of ROS change in SCNT embryos is similar to zona free IVF
derived embryos, except it decrease from two cell stage and regain its value at morula
stage. The sudden rise in ROS at blastocyst stage, further emphasizes the special need of
IVF and SCNT derived embryos during this stage of development.